Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Identification of Concealed and Manifest Long QT Syndrome Using a Novel T Wave Analysis Program

A. Sugrue, PA. Noseworthy, V. Kremen, JM. Bos, B. Qiang, RK. Rohatgi, Y. Sapir, ZI. Attia, P. Brady, SJ. Asirvatham, PA. Friedman, MJ. Ackerman,

. 2016 ; 9 (7) : .

Language English Country United States

Document type Journal Article

BACKGROUND: Congenital long QT syndrome (LQTS) is characterized by QT prolongation. However, the QT interval itself is insufficient for diagnosis, unless the corrected QT interval is repeatedly ≥500 ms without an acquired explanation. Further, the majority of LQTS patients have a corrected QT interval below this threshold, and a significant minority has normal resting corrected QT interval values. Here, we aimed to develop and validate a novel, quantitative T wave morphological analysis program to differentiate LQTS patients from healthy controls. METHODS AND RESULTS: We analyzed a genotyped cohort of 420 patients (22±16 years, 43% male) with either LQT1 (61%) or LQT2 (39%). ECG analysis was conducted using a novel, proprietary T wave analysis program that quantitates subtle changes in T wave morphology. The top 3 discriminating features in each ECG lead were determined and the lead with the best discrimination selected. Classification was performed using a linear discriminant classifier and validated on an untouched cohort. The top 3 features were Tpeak-Tend interval, T wave left slope, and T wave center of gravity x axis (last 25% of the T wave). Lead V6 had the best discrimination. It could distinguish 86.8% of LQTS patients from healthy controls. Moreover, it distinguished 83.33% of patients with concealed LQTS from controls, despite having essentially identical resting corrected QT interval values. CONCLUSIONS: T wave quantitative analysis on the 12-lead surface ECG provides an effective, novel tool to distinguish patients with either LQT1/LQT2 from healthy matched controls. It can provide guidance while mutation-specific genetic testing is in motion for family members.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023855
003      
CZ-PrNML
005      
20170830120339.0
007      
ta
008      
170720s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1161/CIRCEP.115.003830 $2 doi
035    __
$a (PubMed)27406603
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Sugrue, Alan $u From the Division of Internal Medicine (A.S.), Division of Cardiovascular Diseases (P.A.N., V.K., B.Q., R.K.R., Z.I.A., P.B., S.J.A., P.A.F., M.J.A.), Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology (J.M.B., S.J.A., M.J.A.), Mayo Clinic, Rochester, MN; Czech Institute of Informatics, Robotics, and Cybernetics, Czech Technical University in Prague, Czech Republic (V.K.); Electrical and Computer Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel (Y.S., Z.I.A.); Windland Smith Rice Sudden Death Genomics Laboratory, Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN (J.M.B., M.J.A.). ackerman.michael@mayo.edu.
245    10
$a Identification of Concealed and Manifest Long QT Syndrome Using a Novel T Wave Analysis Program / $c A. Sugrue, PA. Noseworthy, V. Kremen, JM. Bos, B. Qiang, RK. Rohatgi, Y. Sapir, ZI. Attia, P. Brady, SJ. Asirvatham, PA. Friedman, MJ. Ackerman,
520    9_
$a BACKGROUND: Congenital long QT syndrome (LQTS) is characterized by QT prolongation. However, the QT interval itself is insufficient for diagnosis, unless the corrected QT interval is repeatedly ≥500 ms without an acquired explanation. Further, the majority of LQTS patients have a corrected QT interval below this threshold, and a significant minority has normal resting corrected QT interval values. Here, we aimed to develop and validate a novel, quantitative T wave morphological analysis program to differentiate LQTS patients from healthy controls. METHODS AND RESULTS: We analyzed a genotyped cohort of 420 patients (22±16 years, 43% male) with either LQT1 (61%) or LQT2 (39%). ECG analysis was conducted using a novel, proprietary T wave analysis program that quantitates subtle changes in T wave morphology. The top 3 discriminating features in each ECG lead were determined and the lead with the best discrimination selected. Classification was performed using a linear discriminant classifier and validated on an untouched cohort. The top 3 features were Tpeak-Tend interval, T wave left slope, and T wave center of gravity x axis (last 25% of the T wave). Lead V6 had the best discrimination. It could distinguish 86.8% of LQTS patients from healthy controls. Moreover, it distinguished 83.33% of patients with concealed LQTS from controls, despite having essentially identical resting corrected QT interval values. CONCLUSIONS: T wave quantitative analysis on the 12-lead surface ECG provides an effective, novel tool to distinguish patients with either LQT1/LQT2 from healthy matched controls. It can provide guidance while mutation-specific genetic testing is in motion for family members.
650    _2
$a elektrokardiografie $x metody $7 D004562
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genotyp $7 D005838
650    _2
$a lidé $7 D006801
650    _2
$a syndrom dlouhého QT $x klasifikace $x diagnóza $x genetika $7 D008133
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a senzitivita a specificita $7 D012680
650    _2
$a počítačové zpracování signálu $7 D012815
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Noseworthy, Peter A $u From the Division of Internal Medicine (A.S.), Division of Cardiovascular Diseases (P.A.N., V.K., B.Q., R.K.R., Z.I.A., P.B., S.J.A., P.A.F., M.J.A.), Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology (J.M.B., S.J.A., M.J.A.), Mayo Clinic, Rochester, MN; Czech Institute of Informatics, Robotics, and Cybernetics, Czech Technical University in Prague, Czech Republic (V.K.); Electrical and Computer Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel (Y.S., Z.I.A.); Windland Smith Rice Sudden Death Genomics Laboratory, Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN (J.M.B., M.J.A.).
700    1_
$a Kremen, Vaclav $u From the Division of Internal Medicine (A.S.), Division of Cardiovascular Diseases (P.A.N., V.K., B.Q., R.K.R., Z.I.A., P.B., S.J.A., P.A.F., M.J.A.), Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology (J.M.B., S.J.A., M.J.A.), Mayo Clinic, Rochester, MN; Czech Institute of Informatics, Robotics, and Cybernetics, Czech Technical University in Prague, Czech Republic (V.K.); Electrical and Computer Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel (Y.S., Z.I.A.); Windland Smith Rice Sudden Death Genomics Laboratory, Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN (J.M.B., M.J.A.).
700    1_
$a Bos, J Martijn $u From the Division of Internal Medicine (A.S.), Division of Cardiovascular Diseases (P.A.N., V.K., B.Q., R.K.R., Z.I.A., P.B., S.J.A., P.A.F., M.J.A.), Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology (J.M.B., S.J.A., M.J.A.), Mayo Clinic, Rochester, MN; Czech Institute of Informatics, Robotics, and Cybernetics, Czech Technical University in Prague, Czech Republic (V.K.); Electrical and Computer Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel (Y.S., Z.I.A.); Windland Smith Rice Sudden Death Genomics Laboratory, Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN (J.M.B., M.J.A.).
700    1_
$a Qiang, Bo $u From the Division of Internal Medicine (A.S.), Division of Cardiovascular Diseases (P.A.N., V.K., B.Q., R.K.R., Z.I.A., P.B., S.J.A., P.A.F., M.J.A.), Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology (J.M.B., S.J.A., M.J.A.), Mayo Clinic, Rochester, MN; Czech Institute of Informatics, Robotics, and Cybernetics, Czech Technical University in Prague, Czech Republic (V.K.); Electrical and Computer Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel (Y.S., Z.I.A.); Windland Smith Rice Sudden Death Genomics Laboratory, Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN (J.M.B., M.J.A.).
700    1_
$a Rohatgi, Ram K $u From the Division of Internal Medicine (A.S.), Division of Cardiovascular Diseases (P.A.N., V.K., B.Q., R.K.R., Z.I.A., P.B., S.J.A., P.A.F., M.J.A.), Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology (J.M.B., S.J.A., M.J.A.), Mayo Clinic, Rochester, MN; Czech Institute of Informatics, Robotics, and Cybernetics, Czech Technical University in Prague, Czech Republic (V.K.); Electrical and Computer Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel (Y.S., Z.I.A.); Windland Smith Rice Sudden Death Genomics Laboratory, Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN (J.M.B., M.J.A.).
700    1_
$a Sapir, Yehu $u From the Division of Internal Medicine (A.S.), Division of Cardiovascular Diseases (P.A.N., V.K., B.Q., R.K.R., Z.I.A., P.B., S.J.A., P.A.F., M.J.A.), Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology (J.M.B., S.J.A., M.J.A.), Mayo Clinic, Rochester, MN; Czech Institute of Informatics, Robotics, and Cybernetics, Czech Technical University in Prague, Czech Republic (V.K.); Electrical and Computer Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel (Y.S., Z.I.A.); Windland Smith Rice Sudden Death Genomics Laboratory, Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN (J.M.B., M.J.A.).
700    1_
$a Attia, Zachi I $u From the Division of Internal Medicine (A.S.), Division of Cardiovascular Diseases (P.A.N., V.K., B.Q., R.K.R., Z.I.A., P.B., S.J.A., P.A.F., M.J.A.), Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology (J.M.B., S.J.A., M.J.A.), Mayo Clinic, Rochester, MN; Czech Institute of Informatics, Robotics, and Cybernetics, Czech Technical University in Prague, Czech Republic (V.K.); Electrical and Computer Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel (Y.S., Z.I.A.); Windland Smith Rice Sudden Death Genomics Laboratory, Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN (J.M.B., M.J.A.). $7 gn_A_00009865
700    1_
$a Brady, Peter $u From the Division of Internal Medicine (A.S.), Division of Cardiovascular Diseases (P.A.N., V.K., B.Q., R.K.R., Z.I.A., P.B., S.J.A., P.A.F., M.J.A.), Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology (J.M.B., S.J.A., M.J.A.), Mayo Clinic, Rochester, MN; Czech Institute of Informatics, Robotics, and Cybernetics, Czech Technical University in Prague, Czech Republic (V.K.); Electrical and Computer Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel (Y.S., Z.I.A.); Windland Smith Rice Sudden Death Genomics Laboratory, Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN (J.M.B., M.J.A.).
700    1_
$a Asirvatham, Samuel J $u From the Division of Internal Medicine (A.S.), Division of Cardiovascular Diseases (P.A.N., V.K., B.Q., R.K.R., Z.I.A., P.B., S.J.A., P.A.F., M.J.A.), Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology (J.M.B., S.J.A., M.J.A.), Mayo Clinic, Rochester, MN; Czech Institute of Informatics, Robotics, and Cybernetics, Czech Technical University in Prague, Czech Republic (V.K.); Electrical and Computer Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel (Y.S., Z.I.A.); Windland Smith Rice Sudden Death Genomics Laboratory, Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN (J.M.B., M.J.A.). $7 gn_A_00009398
700    1_
$a Friedman, Paul A $u From the Division of Internal Medicine (A.S.), Division of Cardiovascular Diseases (P.A.N., V.K., B.Q., R.K.R., Z.I.A., P.B., S.J.A., P.A.F., M.J.A.), Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology (J.M.B., S.J.A., M.J.A.), Mayo Clinic, Rochester, MN; Czech Institute of Informatics, Robotics, and Cybernetics, Czech Technical University in Prague, Czech Republic (V.K.); Electrical and Computer Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel (Y.S., Z.I.A.); Windland Smith Rice Sudden Death Genomics Laboratory, Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN (J.M.B., M.J.A.).
700    1_
$a Ackerman, Michael J $u From the Division of Internal Medicine (A.S.), Division of Cardiovascular Diseases (P.A.N., V.K., B.Q., R.K.R., Z.I.A., P.B., S.J.A., P.A.F., M.J.A.), Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology (J.M.B., S.J.A., M.J.A.), Mayo Clinic, Rochester, MN; Czech Institute of Informatics, Robotics, and Cybernetics, Czech Technical University in Prague, Czech Republic (V.K.); Electrical and Computer Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel (Y.S., Z.I.A.); Windland Smith Rice Sudden Death Genomics Laboratory, Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN (J.M.B., M.J.A.). ackerman.michael@mayo.edu. $7 gn_A_00001006
773    0_
$w MED00159578 $t Circulation. Arrhythmia and electrophysiology $x 1941-3084 $g Roč. 9, č. 7 (2016)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27406603 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170830120928 $b ABA008
999    __
$a ok $b bmc $g 1239536 $s 984768
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 9 $c 7 $i 1941-3084 $m Circulation. Arrhythmia and electrophysiology $n Circ Arrhythm Electrophysiol $x MED00159578
LZP    __
$a Pubmed-20170720

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...